136 drugs collectively raise prices, the increase is more than 3000%

 On December 21, the Centralized Procurement Network of Medicines and Medical Consumables in Liaoning Province issued the "Notice on Announcement of the Dynamic Adjustment of Drug Online Prices", which proposed to increase the online prices of 136 drugs
.
Among them, 9 drugs increased by more than 1000%, with the highest increase of 3,07.
69%
.
According to combing, the price increase involves more than 100 chemical medicines and Chinese patent medicines, with the increase ranging from 0.
04% to more than 3000%
.
Among the drugs announced, Ribavirin injection (1ml:0.
1g) produced by Henan Furen Huaiqingtang Pharmaceutical Co.
, Ltd.
has the highest price increase
.
At present, the online price in Liaoning Province is 0.
52 yuan/piece, and it is proposed to increase the price to 19.
8 yuan/piece, an increase of 3708%
.
Data show that ribavirin injection is mainly used for viral pneumonia and bronchitis caused by respiratory syncytial virus, and is a commonly used antiviral drug
.
In addition, the amikacin sulfate injection (2ml: 0.
2g (200,000 units)) produced by Furen Huaiqingtang has increased by more than 15 times, and the price will be raised from 1.
01 yuan/piece to 16.
5 yuan/piece
.
Data show that Amikacin Sulfate Injection is mainly used for severe infections caused by sensitive Gram-negative bacilli and Staphylococcus (methicillin-sensitive strains), and is a common antibiotic
.
Pingyangmycin hydrochloride for injection from Jilin Aodong Pharmaceutical Co.
, Ltd.
rose from 148 yuan to 794 yuan; Nanjing Nanda Pharmaceutical Co.
, Ltd.
's urokinase for injection rose from 74.
9 yuan to 498 yuan; and Hanhui Pharmaceutical’s injection Bleomycin hydrochloride rose from 119 yuan to 398 yuan
.
There were 9 companies with an increase of over 1000%, including Ribavirin injection and Amikacin sulfate injection from Henan Furen Huaiqingtang Pharmaceutical, Henan Runhong Pharmaceutical's Neostigmine Methsulfate Injection, Hunan Dongting Aminomethylbenzoic acid injection medicine, pharmaceutical Jiangsu with the light-fluoro flunarizine hydrochloride capsules, Ferrer Church pharmaceutical Jiaozuo two specifications Xiangdan injection, Shandong Saint-Leu pharmaceutical nitroglycerin injection and the like
.
For example, Runhong Pharmaceutical intends to increase the price of neostigmine methosulfate injection (1ml: 0.
5mg) to 36 yuan/piece, which is nearly 13 times higher than the current online price (2.
6 yuan/piece)
.
Shanghai Xinyi Jinzhu Pharmaceutical Co.
, Ltd.
plans to increase the price of 2ml: 1mg drugs from 4.
5 yuan per bottle to 71.
5 yuan
.
In addition, among the drugs whose prices have increased this time, 9 drugs in Yan’an Bikang’s wholly-owned subsidiary have increased in price by 32%-111.
2%; and 3 Gorges Pharmaceuticals, a wholly-owned subsidiary of Renfu Pharmaceutical, has increased in two varieties, including mannitol injection.
Soaring 570%
.
The price increase of medicines this time, rising costs are one of the important factors
.
Analysts said that since the beginning of this year, the prices of raw materials have been rising frequently, with the increase generally reaching two to three times
.
As production costs increase, corporate profits are correspondingly reduced.
In order not to lose their qualifications for recruiting and purchasing due to dishonesty, some companies can barely supply products
.
In addition to price increases, Liaoning adjusted the prices of these drugs this time, perhaps to prevent supply cuts and ensure clinical supply
.
It is reported that compared with the current online prices for the 136 drugs involved, the price increase is quite different.
The highest price increase is more than 30 times, the lowest price increase is less than 1%, and most of the price increases are less than 2 times.

.
However, it should be noted that these prices are only the declared prices of the enterprises, and there will be no objections after the announcement will become the purchase prices of Liaoning Province
.
However, Liaoning Province will not necessarily purchase drugs from these companies in the end, but preferentially choose other manufacturers that have not raised prices
.